The Aimee Crago Lab: Publications

Share
Print
Share
Print

Chmielecki J*, Crago AM*, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (*equal contribution). Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nature Genetics Feb 2013; 45:131-132. PMCID: PMC3984043.

Crago AM, Socci ND, DeCarolis P, O’Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clin Cancer Res Mar 2012; 18:1334-40. PMCID: PMC3294014.

Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, Gonen M, Singer S, Brennan MF. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of Surgery Aug 2013; 258:347-353.

Kovatcheva, M, Liu, D, Klein, M, Dickson, M, O’Connor, R, Socci, ND, Tap, WD, Schwartz, G, Singer, S, Crago, AM* and Koff, A* (*co-corresponding). MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget, Apr 2015; 6:8226-43.  PMCID:PMC25803170

Crago, AM, Chmielecki, J., Rosenberg, M., O’Connor, R., Byrne, C., Wilder, FG, Agius, P, Socci, ND, Qin, LX, Meyerson, M, Hameed, M, and Singer S. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes, Chromosomes and Cancer, Oct 2015; 54:606-15.  PMCID:PMC26171757.